The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide

🤖 Plain-English Summary

The data sources and methods used to develop global cancer incidence and mortality statistics-the GLOBOCAN estimates-for the year 2022 are documented in this article, alongside a brief overview of the global cancer burden. With 2.30 million (2.28-2.30) new cases estimated in 2022, breast cancer was the most diagnosed cancer in females, followed by lung cancer (0.91 million [0.90-0.91 million]) and cervical cancer (0.66 million [0.66-0.67]).

🔑 Key Findings

• The estimates, made available in 185 countries or territories worldwide for 36 cancer sites by sex and age, are based on the best available local data sources, namely population-based cancer registries (for incidence) and national vital statistics (for mortality).
• In males, lung cancer was the most commonly diagnosed cancer worldwide in 2022 (1.57 million new cases [95% UI: 1.56-1.58]), followed by prostate cancer (1.47 million [1.46-1.48]).
• With 2.30 million (2.28-2.30) new cases estimated in 2022, breast cancer was the most diagnosed cancer in females, followed by lung cancer (0.91 million [0.90-0.91 million]) and cervical cancer (0.66 million [0.66-0.67]).

🔗 Related Resources